Benitec Biopharma (BNTC) Other Gross PP&E Adjustments (2019 - 2025)

Benitec Biopharma's Other Gross PP&E Adjustments history spans 7 years, with the latest figure at $1.4 million for Q1 2025.

  • For Q1 2025, Other Gross PP&E Adjustments rose 29.79% year-over-year to $1.4 million; the TTM value through Mar 2025 reached $1.4 million, up 29.79%, while the annual FY2024 figure was $1.0 million, 65.55% up from the prior year.
  • Other Gross PP&E Adjustments for Q1 2025 was $1.4 million at Benitec Biopharma, up from $1.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $1.4 million in Q1 2025 and bottomed at $394000.0 in Q3 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $630000.0 (2022), against an average of $804941.2.
  • The largest annual shift saw Other Gross PP&E Adjustments crashed 66.87% in 2022 before it skyrocketed 66.77% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $408000.0 in 2021, then skyrocketed by 53.92% to $628000.0 in 2022, then surged by 38.38% to $869000.0 in 2023, then surged by 50.86% to $1.3 million in 2024, then rose by 3.36% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Other Gross PP&E Adjustments are $1.4 million (Q1 2025), $1.3 million (Q4 2024), and $1.3 million (Q3 2024).